Evonik Industries/€EVK
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Evonik Industries
Evonik Industries AG, a German multinational, specializes in producing specialty chemicals, primarily focusing on consumer goods, animal nutrition, and pharmaceuticals. Founded in 1873, the company operates globally and is structured into multiple segments including Specialty Additives, Nutrition & Care, and Smart Materials among others. As a publicly traded entity, it is listed on the Frankfurt Stock Exchange under the ticker EVK.
Ticker
€EVK
Sector
Primary listing
XETRA
Employees
31,273
Headquarters
Website
EVK Metrics
BasicAdvanced
€6.9B
16.29
€0.92
0.94
€1.17
7.83%
Price and volume
Market cap
€6.9B
Beta
0.94
52-week high
€22.39
52-week low
€14.18
Average daily volume
154K
Dividend rate
€1.17
Financial strength
Current ratio
1.446
Quick ratio
0.544
Long term debt to equity
39.642
Total debt to equity
52.915
Dividend payout ratio (TTM)
128.54%
Interest coverage (TTM)
3.76%
Profitability
EBITDA (TTM)
1,665
Gross margin (TTM)
25.70%
Net profit margin (TTM)
2.88%
Operating margin (TTM)
5.53%
Effective tax rate (TTM)
28.94%
Revenue per employee (TTM)
€470,000
Management effectiveness
Return on assets (TTM)
2.59%
Return on equity (TTM)
5.00%
Valuation
Price to earnings (TTM)
16.29
Price to revenue (TTM)
0.47
Price to book
0.81
Price to tangible book (TTM)
2.07
Price to free cash flow (TTM)
13.463
Free cash flow yield (TTM)
7.43%
Free cash flow per share (TTM)
1.11
Dividend yield (TTM)
7.83%
Forward dividend yield
7.83%
Growth
Revenue change (TTM)
-2.62%
Earnings per share change (TTM)
-573.34%
3-year revenue growth (CAGR)
-5.14%
10-year revenue growth (CAGR)
0.93%
3-year earnings per share growth (CAGR)
-23.40%
10-year earnings per share growth (CAGR)
-7.59%
10-year dividend per share growth (CAGR)
1.58%
What the Analysts think about EVK
Analyst ratings (Buy, Hold, Sell) for Evonik Industries stock.
Bulls say / Bears say
Evonik’s first-quarter 2025 adjusted EBITDA increased 7% to €560 million, beating the €543 million consensus, thanks to strong growth in Nutrition & Care and disciplined cost controls, highlighting resilience in high-margin areas.
The May 2025 strategic plan targets a €1 billion core profit boost by 2027, split equally between €500 million in internal growth—using higher utilization at new plants and product innovation—and €500 million from efficiency improvements, providing a clear path to better margins.
The merger of Marl and Wesseling chemical services into Syneqt GmbH, scheduled for January 2026, will consolidate over €1.8 billion in annual revenue within one entity, which could improve operational efficiency and position the company for future partnerships or asset sales.
Evonik reduced its 2025 adjusted EBITDA outlook to about €1.9 billion, which is below its previous €2.0–2.3 billion range and the €1.96 billion consensus, due to ongoing weak demand that makes near-term earnings less predictable.
The company’s broad restructuring—including likely workforce cuts exceeding 20% and a two-year pause on acquisitions—suggests major internal challenges that could hurt employee morale and limit strategic options.
CEO Christian Kullmann cautioned that a possible economic slowdown in the second half of 2025, driven by U.S. protectionist trade policies and subdued global demand, increases the risk of revenue and margin declines.
Data summarised monthly by Lightyear AI. Last updated on 9 Oct 2025.
EVK Financial Performance
Revenues and expenses
EVK Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Evonik Industries stock?
Evonik Industries (EVK) has a market cap of €6.9B as of October 20, 2025.
What is the P/E ratio for Evonik Industries stock?
The price to earnings (P/E) ratio for Evonik Industries (EVK) stock is 16.29 as of October 20, 2025.
Does Evonik Industries stock pay dividends?
Yes, the Evonik Industries (EVK) stock pays dividends to shareholders. As of October 20, 2025, the dividend rate is €1.17 and the yield is 7.83%. Evonik Industries has a payout ratio of 128.54% on a trailing twelve-month basis.
When is the next Evonik Industries dividend payment date?
The next Evonik Industries (EVK) dividend payment date is unconfirmed.
What is the beta indicator for Evonik Industries?
Evonik Industries (EVK) has a beta rating of 0.94. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.